Page 674 - Williams Hematology ( PDFDrive )
P. 674

648  Part VI:  The Erythrocyte                                    Chapter 43:  Iron Deficiency and Overload           649




                    261. Ganz T, Goff J, Klasing K, et al: IOD in rhinos—immunity group report: Report from     273. Vaiopoulos G, Papanikolaou G, Politou M, et al: Arthropathy in juvenile hemochroma-
                     the Immunity, Genetics and Toxicology Working Group of the International Workshop   tosis. Arthritis Rheum 48(1):227–230, 2003.
                     on Iron Overload Disorder in Browsing Rhinoceros (February 2011). J Zoo Wildl Med     274. Ko C, Siddaiah N, Berger J, et al: Prevalence of hepatic iron overload and association
                     43(3 Suppl):S117–S119, 2012.                          with hepatocellular cancer in end-stage liver disease: Results from the National Hemo-
                    262. Yang T, Brittenham GM, Dong WQ, et al: Deferoxamine prevents cardiac hypertro-  chromatosis Transplant Registry. Liver Int 27(10):1394–1401, 2007.
                     phy and failure in the gerbil model of iron-induced cardiomyopathy. J Lab Clin Med     275. Ryan CF, Sendi H, Bonkovsky HL: Hepatitis C, porphyria cutanea tarda and liver iron:
                     142(5):332–340, 2003.                                 An update. Liver Int 32(6):880–893, 2012.
                    263. Brittenham GM, Kuryshev YA, Obejero-Paz CA, et al: Yang et al response. J Lab Clin     276. Camaschella C, Roetto A, De GM: Juvenile hemochromatosis.  Semin Hematol
                     Med 141(6):420–422, 2003.                             39(4):242–248, 2002.
                    264. Wood JC, Otto-Duessel M, Gonzalez I, et al: Deferasirox and deferiprone remove car-    277. Bottomley SS: Secondary iron overload disorders. Semin Hematol 35(1):77–86, 1998.
                     diac iron in the iron-overloaded gerbil. Transl Res 148(5):272–280, 2006.    278. Jensen PD: Evaluation of iron overload. Br J Haematol 124(6):697–711, 2004.
                    265. Hershko C, Link G, Konijn AM, et al: The iron-loaded gerbil model revisited: Effects of     279. Poullis A, Moodie SJ, Ang L, et al: Routine transferrin saturation measurement in liver
                     deferoxamine and deferiprone treatment. J Lab Clin Med 139(1):50–58, 2002.  clinic patients increases detection of hereditary haemochromatosis. Ann Clin Biochem
                    266. Zhou XY, Tomatsu S, Fleming RE, et al: HFE gene knockout produces mouse model of   40(Pt 5):521–527, 2003.
                     hereditary hemochromatosis. Proc Natl Acad Sci U S A 95(5):2492–2497, 1998.    280. Yin D, Kulhalli V, Walker AP: Raised serum ferritin concentration in hereditary
                    267. Donovan A, Lima CA, Pinkus JL, et al: The iron exporter ferroportin/Slc40a1 is essen-  hyperferritinemia cataract syndrome is not a marker for iron overload.  Hepatology
                     tial for iron homeostasis. Cell Metab 1(3):191–200, 2005.  59(3):1204–1206, 2014.
                    268. Lesbordes-Brion JC, Viatte L, Bennoun M, et al: Targeted disruption of the hepcidin 1     281. Brissot P, Bardou-Jacquet E, Jouanolle AM, et al: Iron disorders of genetic origin: A
                     gene results in severe hemochromatosis. Blood 108(4):1402–1405, 2006.  changing world. Trends Mol Med 17(12):707–713, 2011.
                    269. Meynard D, Kautz L, Darnaud V, et al: Lack of the bone morphogenetic protein BMP6     282. Porter JB: Practical management of iron overload. Br J Haematol 115(2):239–252, 2001.
                     induces massive iron overload. Nat Genet 41(4):478–481, 2009.    283. Hoffbrand AV, Taher A, Cappellini MD: How I treat transfusional iron overload. Blood
                    270. Andriopoulos B, Jr, Corradini E, Xia Y, et al: BMP6 is a key endogenous regulator of   120(18):3657–3669, 2012.
                     hepcidin expression and iron metabolism. Nat Genet 41(4):482–487, 2009.    284. Ogimoto M, Anzai K, Takenoshita H, et al: Criteria for early identification of aceru-
                    271. Carroll GJ, Breidahl WH, Bulsara MK, et al: Hereditary hemochromatosis is character-  loplasminemia. Intern Med 50(13):1415–1418, 2011.
                     ized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum     285. Grandchamp B, Hetet G, Kannengiesser C, et al: A novel type of congenital hypochro-
                     63(1):286–294, 2011.                                  mic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene. Blood
                    272. Elmberg M, Hultcrantz R, Simard JF, et al: Increased risk of arthropathies and joint   118(25):6660–6666, 2011.
                     replacement surgery in patients with genetic hemochromatosis: A study of 3,531
                     patients and their 11,794 first-degree relatives.  Arthritis Care Res (Hoboken) 65(5):
                     678–685, 2013.




























































          Kaushansky_chapter 43_p0627-0650.indd   649                                                                   9/17/15   6:27 PM
   669   670   671   672   673   674   675   676   677   678   679